date,title,source
Oct-18-18,Ultragenyx Announces Approval of Mepsevii (vestronidase alfa) in Brazil for the Treatment of Mucopolysaccharidosis VII,GlobeNewswire
Oct-22-18,Ultragenyx Announces Exclusive License to REGENXBIO AAV Vectors to Develop Gene Therapy for CDD (CDKL5 Deficiency Disorder),GlobeNewswire
Oct-26-18,Ultragenyx Announces Negative Topline Results from Phase 3 Study of UX007 in Patients with Glut1 DS with Disabling Movement Disorders,GlobeNewswire
Oct-30-18,Ultragenyx to Host Conference Call for Third Quarter 2018 Financial Results and Corporate Update,GlobeNewswire
Oct-31-18,"Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q3, DRNA Soars on LLY Deal",Zacks
Nov-05-18,"Ultragenyx (RARE) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-05-18,Ultragenyx: 3Q Earnings Snapshot,Associated Press
Nov-05-18,Ultragenyx Reports Third Quarter 2018 Financial Results and Corporate Update,GlobeNewswire
Nov-06-18,Ultragenyx (RARE) Posts Narrower-Than-Expected Loss in Q3,Zacks
Nov-06-18,Edited Transcript of RARE earnings conference call or presentation 5-Nov-18 10:00pm GMT,Thomson Reuters StreetEvents
Nov-06-18,"Amazon, Pandora, PTC Therapeutics, and More: Why These Stocks Are Trending",Insider Monkey
Nov-09-18,Ultragenyx to Present at Upcoming Investor Conferences,GlobeNewswire
Nov-09-18,"Report: Exploring Fundamental Drivers Behind AcelRx Pharmaceuticals, Fossil Group, FMC, Ultragenyx Pharmaceutical, Shenandoah Telecommunications, and Marcus & Millichap  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Nov-14-18,Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Mid-2019,GlobeNewswire
Nov-19-18,Edited Transcript of RARE earnings conference call or presentation 5-Nov-18 10:00pm GMT,Thomson Reuters StreetEvents
Nov-21-18,Edited Transcript of RARE earnings conference call or presentation 5-Nov-18 10:00pm GMT,Thomson Reuters StreetEvents
Dec-06-18,Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita (burosumab injection) for the Treatment of Xlinked Hypophosphatemia (XLH) in Adults and Children,GlobeNewswire
Dec-13-18,Today's Research Reports on Trending Tickers: Intercept Pharmaceuticals and Ultragenyx Pharmaceutical,ACCESSWIRE
Dec-19-18,Hedge Funds Are Crazy About Ultragenyx Pharmaceutical Inc (RARE),Insider Monkey
Jan-03-19,Outlook For Battered Biotech Stocks In 2019,Investopedia
Jan-03-19,Analysts Issue New Ratings on Large Health Care Stocks,GuruFocus.com
Jan-03-19,Ultragenyx to Present at J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-04-19,This Biotech Stock Is Flying On Its Promising Gene Therapy,Investor's Business Daily
Jan-04-19,Ultragenyx Announces Positive Topline Results from First Cohort of Phase 1/2 Clinical Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia,GlobeNewswire
Jan-08-19,"At biotech's big event, a chance for execs to shape LGBTQ diversity on boards",American City Business Journals
Jan-11-19,"New Research Coverage Highlights Arthur J. Gallagher, Ultragenyx Pharmaceutical, Empire State Realty Trust, ConocoPhillips, Kilroy Realty, and NETGEAR  Consolidated Revenues, Company Growth, and Expectations for 2019",GlobeNewswire
Jan-11-19,Today's Research Reports on Trending Tickers: bluebird bio and Ultragenyx Pharmaceutical,ACCESSWIRE
Jan-17-19,J&amp;J (JNJ) to Commence Pharma Q4 Earnings: What to Expect,Zacks
Jan-22-19,Ultragenyx stock up 2.9% after safety and efficacy trial reaffirms Phase 2 data,MarketWatch
Jan-22-19,Ultragenyx Announces Positive Topline Data from Ongoing Long-Term Extension Study of UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders,GlobeNewswire
Feb-04-19,"Ultragenyx Appoints Shehnaaz Suliman, M.D., to Board of Directors",GlobeNewswire
Feb-06-19,Is Ultragenyx Pharmaceutical Inc.s (NASDAQ:RARE) Liquidity Good Enough?,Simply Wall St.
Feb-12-19,Will Ultragenyx (RARE) Report Negative Q4 Earnings? What You Should Know,Zacks
Feb-12-19,Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2018 Financial Results and Corporate Update,GlobeNewswire
Feb-19-19,Ultragenyx: 4Q Earnings Snapshot,Associated Press
Feb-19-19,Ultragenyx Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Update,GlobeNewswire
Feb-19-19,"Ultragenyx Pharmaceutical, Inc. to Host Earnings Call",ACCESSWIRE
Feb-20-19,Here's Why This Small Biotech Stock Just Hit A Four-Month High,Investor's Business Daily
Feb-20-19,Edited Transcript of RARE earnings conference call or presentation 19-Feb-19 10:00pm GMT,Thomson Reuters StreetEvents
Feb-20-19,Ultragenyx (RARE) Posts Narrower-Than-Expected Loss in Q4,Zacks
Feb-20-19,Ultragenyx Pharmaceutical Inc (RARE) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-21-19,Edited Transcript of RARE earnings conference call or presentation 19-Feb-19 10:00pm GMT,Thomson Reuters StreetEvents
Feb-21-19,Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia,GlobeNewswire
Feb-21-19,"Report: Exploring Fundamental Drivers Behind Canopy Growth, Adobe, Ultragenyx Pharmaceutical, Humana, Ship Finance International, and NexGen Energy  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Feb-25-19,Ultragenyx Announces Proposed Public Offering of Common Stock,GlobeNewswire
Feb-25-19,Sell-Side Picks Top Gene Therapy Takeout Candidates Following Spark Therapeutics Deal,Benzinga
Feb-25-19,MarketPulse: Roche's Bumper Deal for Spark Therapeutics Boosts Healthcare Stocks,Investing.com
Feb-26-19,Ultragenyx Announces Pricing of Public Offering of Common Stock,GlobeNewswire
Mar-11-19,Ultragenyx to Present at Upcoming Investor Conferences,GlobeNewswire
Mar-21-19,Why Is Ultragenyx (RARE) Up 12.4% Since Last Earnings Report?,Zacks
Mar-27-19,Have Insiders Been Selling Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Shares?,Simply Wall St.
Apr-10-19,Global X Launches GNOM ETF to Tap Booming Genomics Space,Zacks
Apr-11-19,Ultragenyx to Present Corporate Update at Analyst and Investor Day on April 17 in New York,GlobeNewswire
Apr-12-19,Want an insiders way to play IPOs? This fund has had outsize success with its strategy,MarketWatch
Apr-15-19,Want an insiders way to play IPOs? This fund has had outsize success with its strategy,MarketWatch
Apr-16-19,Ultragenyx Announces UX007 Granted Fast Track Designation and Rare Pediatric Disease Designation by U.S. FDA for Treatment of Long-Chain Fatty Acid Oxidation Disorders,GlobeNewswire
Apr-17-19,Ultragenyx's (RARE) UX007 Gets Fast Track Status by FDA,Zacks
Apr-22-19,"Health Care Digest: Attacking a deadly infant virus, Medicaid's smoking gun and exporting genetic expertise",American City Business Journals
Apr-24-19,5 Biotech Stocks Defying the Medicare-for-All Scare,Zacks
Apr-29-19,Arcus (RCUS) to Report Q1 Earnings: What's in the Cards?,Zacks
Apr-29-19,Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?,Zacks
Apr-29-19,Ultragenyx (RARE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?,Zacks
Apr-30-19,Ultragenyx to Host Conference Call for First Quarter 2019 Financial Results and Corporate Update,GlobeNewswire
May-01-19,Did Hedge Funds Drop The Ball On Ultragenyx Pharmaceutical Inc (RARE) ?,Insider Monkey
May-02-19,Protalix (PLX) to Report Q1 Earnings: What's in the Cards?,Zacks
May-03-19,What's in Store for Catalyst Pharma (CPRX) Q1 Earnings?,Zacks
May-03-19,Factors Expected to Influence Qorvo (QRVO) in Q4 Earnings,Zacks
May-06-19,Ultragenyx: 1Q Earnings Snapshot,Associated Press
May-06-19,Ultragenyx Reports First Quarter 2019 Financial Results and Corporate Update,GlobeNewswire
May-07-19,Edited Transcript of RARE earnings conference call or presentation 6-May-19 9:00pm GMT,Thomson Reuters StreetEvents
May-07-19,Ultragenyx (RARE) Reports Wider-Than-Expected Loss in Q1,Zacks
May-07-19,Ultragenyx Pharmaceutical Inc (RARE) Q1 2019 Earnings Call Transcript,Motley Fool
May-10-19,Ultragenyx to Present at Bank of America Merrill Lynch Healthcare Conference,GlobeNewswire
May-23-19,Is Ultragenyx Pharmaceutical Inc.'s (NASDAQ:RARE) CEO Paid At A Competitive Rate?,Simply Wall St.
May-29-19,"Ultragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIOs 2019 Henri A. Termeer Biotechnology Visionary Award",GlobeNewswire
May-31-19,Ultragenyx to Present at Upcoming Investor Conferences,GlobeNewswire
Jun-05-19,Ultragenyx (RARE) Down 5.7% Since Last Earnings Report: Can It Rebound?,Zacks
Jun-11-19,'Something worth doing': How a biotech entrepreneur grew a 700-person company and is conquering rare diseases,American City Business Journals
Jun-17-19,Ultragenyx Expands Leadership Team and Promotes Erik Harris to Chief Commercial Officer,GlobeNewswire
